Projects funded by the NCN
Assessment of the ability of Mycobacterium bovis BCG-onko bacilli to control the development of Helicobacter pylori infection.
2022/47/D/NZ7/01097
Keywords:
Helicobacter pylori BCG immunomodulations
Descriptors:
- NZ7_013:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: SONATA 18 - announced on 2022-07-15
Amount awarded: 1 940 000 PLN
Project start date (Y-m-d): 2023-09-04
Project end date (Y-m-d): 2026-09-03
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (2)
- Spray‑dried pH‑sensitive chitosan microparticles loaded with Mycobacterium bovis BCG intended for supporting treatment of Helicobacter pylori infectionAuthors:Weronika Gonciarz, Marek Brzeziński, Weronika Orłowska, Paweł Wawrzyniak, Artur Lewandowski, Vedha Hari B. Narayanan, Magdalena ChmielaAcademic press:Scientific Reports (rok: 2024, tom: 14, strony: 46040), Wydawca: NatureStatus:PublishedDOI:10.1038/s41598-024-55353-6 - link to the publication
- Mycobacterium bovis BCG reverses deleterious effects of H. pylori components towards gastric barrier cells in vitroAuthors:Weronika Gonciarz, Patrycja Płoszaj, Magdalena ChmielaAcademic press:Biomedicine & Pharmacotherapy (rok: 2024, tom: 178, strony: 46034), Wydawca: ElsevierStatus:PublishedDOI:10.1016/j.biopha.2024.117193 - link to the publication